No data to show
OTCM
BMCS
Market cap2mUSD
May 21, Last price
0.01USD
1D
0.00%
1Q
16.67%
Jan 2017
1,650.00%
Name
BMCS Sumcoin Index Fund Inc
Chart & Performance
P/E
—
P/S
—
EPS
—
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
-72.48%
Revenues
0k
Net income
-6k
L-95.12%
CFO
-27k
L+60.36%
Profile
BioTech Medics, Inc. operates as a medical-based holding company. The company operates medical therapeutic laser centers that treat various pain ailments affecting the muscles, nerves, and bones, as well as arthritis. It also offers SHBAN, an antiseptic hand and body sanitizer. In addition, the company develops and sells nutraceutical products, such as BioBody Balance, a liquid vitamin concentrate; and BioBody Energy Spray, a caffeine and alcohol free natural vitamin energy spray. It offers its nutraceutical products through gross retail sales. The company was incorporated in 1997 and is based in Southlake, Texas with laser pain centers in Texas, California, New Mexico, and Florida.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | (168) | (228) | |||||||
Tax Rate | |||||||||
NOPAT | 168 | 228 | |||||||
Net income | (6) -95.12% | (115) -64.30% | |||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | 30,000 | 18 | |||||||
BB yield | -412.96% | -1.05% | |||||||
| Debt | |||||||||
Debt current | 27 | ||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | (99,973) | (70,000) | |||||||
| Cash flow | |||||||||
Cash from operating activities | (27) | (17) | |||||||
CAPEX | (2) | ||||||||
Cash from investing activities | (30,000) | ||||||||
Cash from financing activities | 30,027 | 18 | |||||||
FCF | 147 | 326 | |||||||
| Balance | |||||||||
Cash | 102 | ||||||||
Long term investments | 100,000 | 70,000 | |||||||
Excess cash | 100,000 | 70,000 | |||||||
Stockholders' equity | (1,658) | 69,779 | |||||||
Invested Capital | 101,255 | (202) | |||||||
ROIC | 0.33% | ||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | 202,356 | 202,356 | |||||||
Price | 0.04 337.80% | 0.01 -87.94% | |||||||
Market cap | 7,265 337.80% | 1,659 -87.94% | |||||||
EV | (92,709) | (68,339) | |||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||